A variety of psychiatric disorders accompany multiple sclerosis (MS),
affecting the spheres of cognition, affect, and personality. These dis
orders may be of primary and/or secondary nature, reflecting, respecti
vely, neurologic damage and/or functional distress associated with a d
isabling disease. Evaluation of the nature, severity, and frequency of
affective symptoms of MS patients is of importance to sensitize the t
reating physician to the possible need for specific psychiatric treatm
ent. We conducted a prospective cross-sectional study assessing correl
ations of psychiatric symptomatology and the neurologic parameters of
disease duration, disease activity (as expressed by the number of dise
ase exacerbations per year), and disease severity (as measured by the
Kurtzke Expanded Disability Status Scale [EDSS]) in 20 relapsing-remit
ting (RR)-MS patients. Patients were also evaluated by a semistructure
d psychiatric interview and the following rating scales: Hamilton Anxi
ety Scale (HAS), Hamilton Depression Scale (HDS), Hackett-Cassem Denia
l Scale, and Lubin Adjective Affective List. Results demonstrated a hi
gh prevalence of anxiety (90%) and to a lesser extent depression (50%)
in RR MS patients. Depression and anxiety were found to be associated
with disease activity, but not with disease duration or severity. The
mechanism of denial played a significant role in the psychiatric prof
ile of the disease and was correlated with disease duration, We sugges
t that in RR-MS patients, psychiatric evaluation should also include a
ssessment of defense and coping mechanisms, which in turn could guide
specific individualized treatment. (C) 1995 by W.B. Saunders Company